BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 16, 2011
View Archived Issues
First-in-class antimicrobial zempia is active against clinical bacterial isolates
Read More
Clinical study determines pharmacokinetics of oral formulation of antibiotic TP-434
Read More
Chemokine CCR8 receptor antagonist R-243 may prevent peritoneal adhesion
Read More
Impax Pharmaceuticals files IND for IPX-159 in restless legs syndrome
Read More
Boehringer Ingelheim patents new chemokine CCR1 receptor antagonists
Read More
Bayer Schering Pharma presents new MEK/ERK inhibitors
Read More
Merck & Co. presents novel kinase inhibitors
Read More
New modulators of muscarinic acetylcholine M1 receptor claimed
Read More
Novartis claims new sodium/glucose cotransporter 2 inhibitors
Read More
Sigma-Tau researchers disclose novel HD6 inhibitors
Read More
Johnson & Johnson recaps highlights of first quarter 2011
Read More
Pfizer outlines milestones for first quarter 2011 and future goals
Read More
Ustekinumab induces responses in patients with Crohn's disease
Read More
Phase II trial compares topical mechlorethamine formulations in mycosis fungoides
Read More
Sanford Project and DiaMedica complete animal study of DM-199
Read More
Merck & Co. completes tender offer to acquire Inspire Pharmaceuticals
Read More
Tourette Syndrome Association and Psyadon Pharmaceuticals collaborate on ecopipam
Read More
FDA approves Victrelis for chronic hepatitis C
Read More
Proteomika licenses HuCAL antibodies from AbD Serotec for use in Promonitor diagnostic kits
Read More
Nuvo Research expands pain portfolio with acquisition of ZARS Pharma
Read More
Chugai files to extend approval of CellCept to pediatric patients in Japan
Read More
Teva signs definitive agreement to acquire Taiyo Pharmaceutical
Read More
Alimera resubmits NDA for Iluvien in diabetic macular edema
Read More
Clavis Pharma licenses anticancer candidate CP-4033 to Translational Therapeutics
Read More
Roche begins phase Ib/II study of TB-403 in brain cancer
Read More